A novel treatment for management of a trapped placenta using intracervical nitroglycerin tablets
- PMID: 24014558
- PMCID: PMC3794125
- DOI: 10.1136/bcr-2013-010505
A novel treatment for management of a trapped placenta using intracervical nitroglycerin tablets
Abstract
A 34-year-old gravida 2, para 1 woman delivered a viable male infant and developed retained placenta due to entrapment. A nitroglycerin tablet was used to relax the lower uterine segment and cervix, which allowed the placenta to pass through the cervix for delivery. The nitroglycerin tablet was placed in the cervix and held in place by the delivering physician as it dissolved. Soon after administration, the intact placenta delivered. The patient did not experience the typical side effects of headache, asymptomatic decrease in blood pressure, hypotension, palpitations or dizziness that can be associated with administration of nitroglycerin. We suspect that this novel localised route of nitroglycerin administration may be an effective management strategy to treat trapped placenta while minimising side effects. However, the outcomes of this treatment would require further study.
Similar articles
-
Sublingual nitroglycerin for management of retained placenta.Int J Gynaecol Obstet. 2005 Dec;91(3):228-32. doi: 10.1016/j.ijgo.2005.08.020. Epub 2005 Oct 14. Int J Gynaecol Obstet. 2005. PMID: 16226759 Clinical Trial.
-
The use of intravenous nitroglycerin for cervico-uterine relaxation: a review of the literature.Arch Gynecol Obstet. 1997;261(1):1-7. doi: 10.1007/s004040050189. Arch Gynecol Obstet. 1997. PMID: 9451516 Review.
-
Nitroglycerin for treatment of retained placenta: A randomised, placebo-controlled, multicentre, double-blind trial in the UK.PLoS Med. 2019 Dec 30;16(12):e1003001. doi: 10.1371/journal.pmed.1003001. eCollection 2019 Dec. PLoS Med. 2019. PMID: 31887169 Free PMC article. Clinical Trial.
-
Intravenous nitroglycerin in the management of retained placenta.Gynecol Obstet Invest. 2003;56(2):61-4. doi: 10.1159/000072734. Epub 2003 Aug 4. Gynecol Obstet Invest. 2003. PMID: 12900527
-
What is the optimal pharmacological management of retained placenta?BMJ. 2014 Jul 28;349:g4778. doi: 10.1136/bmj.g4778. BMJ. 2014. PMID: 25069774 Review. No abstract available.
Cited by
-
Retained Placenta and Postpartum Hemorrhage: A Case Report and Review of Literature.Cureus. 2022 Apr 22;14(4):e24389. doi: 10.7759/cureus.24389. eCollection 2022 Apr. Cureus. 2022. PMID: 35619843 Free PMC article.
-
Nitroglycerin for management of retained placenta.Cochrane Database Syst Rev. 2015 Nov 12;2015(11):CD007708. doi: 10.1002/14651858.CD007708.pub3. Cochrane Database Syst Rev. 2015. PMID: 26558329 Free PMC article.
References
-
- Ekerhovd E, Bullarbo M. Sublingual nitroglycerin seems to be effective in the management of retained placenta. Acta Obstet Gynecol 2008;2013:222–5 - PubMed
-
- Bullarbo M, Tjugum J, Ekerhovd E. Sublingual nitroglycerin for management of retained placenta. Int J Gynecol Obstet 2005;2013:228–32 - PubMed
-
- Wessen A, Elowsson P, Axemo P, et al. The use of intravenous nitroglycerin for emergency cervico-uterine relaxation. Acta Anesthesiol Scand 1995;2013:847–9 - PubMed
-
- Dufour P, Vinatier D, Puech F. The use of intravenous nitroglycerin for cervico-uterine relaxation: a review of the literature. Arch Gynecol Obstet 1997;2013:1–7 - PubMed
-
- Combs C, Laros R. Prolonged third stage of labor: morbidity and risk factors. Obstet Gynecol 1991;2013:863–7 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources